[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362570-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362570-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-of-25-hydroxyvitamin-d-levels-and-vitamin-d-receptor-gene-polymorphisms-with-breast-cancer-risk-in-bangladeshi-women","Association of 25-hydroxyvitamin D levels and vitamin D receptor gene polymorphisms with breast cancer risk in Bangladeshi women","","Breast cancer is a leading cause of mortality among Bangladeshi women, yet evidence on vitamin D status and vitamin D receptor (VDR) genetics in South Asia remains limited. A case–control study of 400 breast cancer patients and 400 age-matched controls evaluated serum 25(OH)D and four VDR variants (rs731236, rs2228570, rs1544410, rs7975232). Logistic regression found significant associations for rs2228570 (FokI) and rs1544410 (BsmI) under dominant models and showed lower 25(OH)D levels in cases. Low 25(OH)D independently increased risk and no variant correlated with 25(OH)D levels.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-of-25-hydroxyvitamin-d-levels-and-vitamin-d-receptor-gene-polymorphisms-with-breast-cancer-risk-in-bangladeshi-women/362570/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-of-25-hydroxyvitamin-d-levels-and-vitamin-d-receptor-gene-polymorphisms-with-breast-cancer-risk-in-bangladeshi-women/362570.png","ImageObject",300,407,{"name":42,"@type":43},"Maya Linwood","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of the study?","Question",{"text":63,"@type":64},"To evaluate whether serum 25-hydroxyvitamin D levels and specific VDR gene polymorphisms are associated with breast cancer risk in Bangladeshi women.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which VDR variants showed significant associations with breast cancer risk?",{"text":68,"@type":64},"Under dominant models, rs2228570 (FokI) and rs1544410 (BsmI) were significantly associated with increased risk.",{"name":70,"@type":61,"acceptedAnswer":71},"How did serum 25(OH)D levels differ between cases and controls?",{"text":72,"@type":64},"Serum 25(OH)D levels were lower in breast cancer cases than in controls, and 80.7% of cases were deficient.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362570,1790645662,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAssociation of 25-hydroxyvitamin D levels and vitamin D receptor gene polymorphisms with breast cancer risk in Bangladeshi women  \nRaushanara Akter1􀀍, Md. Siddiqul Islam2, Abu Syed Md. Mosaddek3, Md. Waheed Akhtar4, Afrina Afrose1, Md. Aminul Haque1, Faruque Azam1,5, Sabrina Sharmin1, Raquibul Hasan6, M. Mahboob Hossain7, Ranjan Kumar Bhowmick8 & Muhammad Asaduzzaman1  \nBreast cancer (BrCa) is a leading cause of mortality among Bangladeshi women. Deficiency of 25-hydroxyvitamin D [25(OH)D] and vitamin D receptor (VDR) polymorphisms have been linked to cancer susceptibility, but evidence from South Asia is scarce. We conducted a case–control study of 400 BrCa patients and 400 age-matched controls to assess serum 25(OH)D levels and four VDR variants (rs731236, rs2228570, rs1544410, rs7975232) in relation to BrCa risk. Logistic regression showed significant associations for rs2228570 (FokI; odds ratio [OR] 1.52, 95% confidence interval [CI] 1.14–  \n2.02, p = 0.004) and rs1544410 (BsmI; OR 1.52, 95% CI 1.14–2.02, p = 0.0044) under dominant models, while rs731236 (TaqI) and rs7975232 (ApaI) showed no effect. Serum 25(OH)D levels were lower in cases than controls, with 80.7% of cases deficient; low 25(OH)D was associated with increased risk (OR 2.15, 95% CI 1.06–4.38, p = 0.035) . No variant correlated with 25(OH)D levels. These findings suggest that FokI, BsmI, and low 25(OH)D independently contribute to BrCa risk in Bangladeshi women.  \nBreast cancer (BrCa) is a critical global health issue, representing the most frequently diagnosed cancer among women and a leading cause of cancer-related mortality worldwide1,2. In 2020, approximately 2.26 million new cases were reported globally, with Bangladesh accounting for a notable proportion of South Asian cases3,4. The International Agency for Research on Cancer (IARC) estimates that over 13,000 Bangladeshi women are diagnosed annually, with more than 7,000 succumbing to the disease5. This rising burden underscores the urgency of identifying modifiable risk factors, particularly in underrepresented populations like Bangladeshi women, where genetic and environmental data are scarce6.  \nVitamin D, a fat-soluble secosteroid hormone, is synthesized in the skin from 7-dehydrocholesterol upon exposure to sunlight or obtained through diet and supplements. It undergoes hydroxylation in the liver, primarily by CYP2R1 (and to a lesser extent CYP27A1), to form 25-hydroxyvitamin D [25(OH)D], which is then converted in the kidney by 1α-hydroxylase (CYP27B1) to its active metabolite, 1,25-dihydroxyvitamin D [1,25(OH)₂D], or Vitamin D3 or calcitriol7. Serum 25(OH)D levels below 20 ng/mL indicate deficiency, 21–29 ng/mL insufficiency, and 30–100 ng/mL sufficiency8. Beyond its classical role in calcium homeostasis and bone metabolism, vitamin D exerts antiproliferative, pro-differentiative, and pro-apoptotic effects via the VDR, a nuclear transcription factor9. Epidemiological studies have demonstrated an inverse relationship between 25(OH)D levels and BrCa risk, with deficiency associated with increased susceptibility and sufficiency with improved prognosis10–12.  \nThe VDR gene, located on chromosome 12q12-14, encodes a receptor expressed in various tissues, including normal and malignant breast cells13. By binding 1,25(OH)₂D, VDR regulates the transcription of genes involved in cell growth and apoptosis, potentially mitigating cancer development14. However, single-nucleotide polymorphisms (SNPs) in the VDR gene, such as rs731236 (TaqI), rs2228570 (FokI), rs1544410 (BsmI), andrs7975232 (ApaI), may alter its expression, stability, or function, influencing BrCa risk15. These SNPs, notably  \n1School of Pharmacy, BRAC University, Kha 224 Bir Uttam Rafiqul Islam Avenue, Merul Badda, Dhaka 1212, Bangladesh. 2Department of Pharmacy, American International University-Bangladesh, Dhaka, Bangladesh.  \n3Department of Pharmacology, Uttar","cbCaidoAGHzsXtDY","https://ap.wps.com/l/cbCaidoAGHzsXtDY","pdf",1979064,"English","# Background\n# Vitamin D biology and VDR mechanisms\n# Study design and genetic variants\n# Statistical findings and associations\n# Discussion and implications","[{\"question\":\"What was the purpose of the study?\",\"answer\":\"To evaluate whether serum 25-hydroxyvitamin D levels and specific VDR gene polymorphisms are associated with breast cancer risk in Bangladeshi women.\"},{\"question\":\"Which VDR variants showed significant associations with breast cancer risk?\",\"answer\":\"Under dominant models, rs2228570 (FokI) and rs1544410 (BsmI) were significantly associated with increased risk.\"},{\"question\":\"How did serum 25(OH)D levels differ between cases and controls?\",\"answer\":\"Serum 25(OH)D levels were lower in breast cancer cases than in controls, and 80.7% of cases were deficient.\"}]","Association of 25-hydroxyvitamin D levels and vitamin D receptor gene polymorphisms with breast cancer risk in Bangladeshi women | PDF",1790148337,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfb3e4fb9245401da346ce4a5b90b927.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e22ce55eadeff8d7a58f154b08b65a04.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fbb16c25e4bc8d09a12e38ee9c3a7fe.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2dc3923ea60fd8cc097aef942808fa59.webp",980,1287]